Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Flea and Tick Control Medication Market

Flea and Tick Control Medication Market Size

  • Report ID: GMI10734
  • Published Date: Aug 2024
  • Report Format: PDF

Flea and Tick Control Medication Market Size

Flea and Tick Control Medication Market size was valued at USD 6.7 billion and is projected to witness a CAGR of 7.1% from 2024 to 2032. The market's robust growth can be attributed to the rising incidence of flea and tick-borne diseases in pets. This has heightened pet owners' awareness of the significance of preventive healthcare, leading to a surge in demand for effective control products.

 

Additionally, the global rise in pet ownership plays a pivotal role in this market expansion. For example, a report from the American Pet Products Association (APPA) highlights that 67% of U.S. households, translating to 85 million families, own pets, a trend that is increasingly observed worldwide. This increasing pet population, combined with heightened expenditure on pet healthcare, propels the demand for flea and tick medications. Moreover, innovations in product formulations, such as new active ingredients and combination products, have improved the efficacy and safety of treatments, further fueling market growth.
 

Flea and tick control medications are pharmaceutical products designed to prevent, eliminate, and manage infestations of fleas, ticks, and other external parasites, primarily on pets like dogs and cats. This market offers a diverse array of products tailored to various species, sizes, and health conditions of pets, addressing both preventative and therapeutic needs.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global flea and tick control medication industry was valued at USD 6.7 billion in 2023 and is anticipated to register 7.1% CAGR between 2024 and 2032 due to the rising incidence of flea and tick-borne diseases in pets.

The chewables segment in the market accounted USD 3.2 billion in 2023, due to their convenience, palatability, and effectiveness.

North America flea and tick control medication market was valued at USD 2.4 billion in 2023, driven by high pet ownership rates, heightened awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure.

Bayer AG, Boehringer Ingelheim International GmbH, Central Garden & Pet Company, Central Life Sciences, Ceva Santé Animale, Ecto Development LLC, Elanco Animal Health Incorporated, and Hartz Mountain Corporation, among others.

Flea and Tick Control Medication Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 485
  • Countries covered: 22
  • Pages: 282
 Download Free Sample